(Q32059749)

6 July 2017

1 reference

title

Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data (English)

1 reference

6 July 2017

0 references

1 reference

1 reference

1 reference

A Mascia

1

1 reference

6 July 2017

J Afra

series ordinal

2

1 reference

6 July 2017

J Schoenen

series ordinal

3

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

6 July 2017

1 reference

6 July 2017

volume

18

1 reference

6 July 2017

issue

4

1 reference

6 July 2017

page(s)

174-182

1 reference

Preclinical Studies on the Anti-Migraine Drug, Sumatriptan

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

On serotonin and migraine: a clinical and pharmacological review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Dopamine, the second putative protagonist in headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

The role of the basal ganglia in nociception and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Successful treatment of thalamic pain with apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Administration of levodopa for relief of herpes zoster pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Dopamine hypersensitivity in migraine: role in apomorphine syncope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Hyperresponsiveness of migraine patients to the hypotensive action of bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Contingent negative variation--findings and perspectives in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Contingent Negative Variation During Migraine Attack and Interval: Evidence for Normalization of Slow Cortical Potentials During the Attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Cognitive processing in primary headache: a study on event-related potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Dopaminergic deficiency causes delayed visual evoked potentials in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Habituation failure of skin conductance response after intraventricular administration of 6-hydroxydopamine in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Repeated stressful experiences differently affect the time-dependent responses of the mesolimbic dopamine system to the stressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Effervescent Metoclopramide and Aspirin (Migravess) Versus Effervescent Aspirin or Placebo for Migraine Attacks: A Double-Blind Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

The efficacy of metoclopramide in the treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Treatment of migraine with intramuscular chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Parenteral chlorpromazine treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

A comparative trial of three agents in the treatment of acute migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Dopamine D2 receptor blockade and antimigraine action of flunarizine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Continuous bromocriptine therapy in menstrual migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Clinical Effectiveness of Lisuride Hydrogen Maleate: A Double-Blind Trial Versus Methysergide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Migraine Prophylaxis with Lisuride Hydrogen Maleate-A Double Blind Study of Lisuride Versus Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

21 January 2018

Dopamine and migraine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

The Dopamine D2 Receptor Locus as a Modifying Gene in Neuropsychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Allelic association of human dopamine D2 receptor gene in alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

Combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine: a multicentre double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-2982.1998.1804174.X

10.1046/J.1468-2982.1998.1804174.X

21 January 2018

Identifiers

DOI

1 reference

release_h6wimntp2jhk5friaqcgoikd3y

6 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h6wimntp2jhk5friaqcgoikd3y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference